Research spotlight: Medicare spending on clinical care for people aging with HIV projected to rise steeply over next decade
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 15:15 ET (25-Oct-2026 19:15 GMT/UTC)
Relying on Artificial Intelligence (AI) in health care also carries a risk that existing racial and gender stereotypes will be reflected in the medical content it generates.
A spinout from the University of Osaka is developing a slim, lightweight, single-use endoscope designed specifically for gastric cancer screening. By simplifying conventional endoscope design, the device aims to reduce patient discomfort, lower costs, and lessen the burden on healthcare professionals. Its disposable format removes the need for cleaning and disinfection, while future integration with AI and digital platforms could support more accessible and efficient screening.
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.
A growing understanding of trained immunity, a form of long-lasting immune system adaptation, is reshaping how scientists view diabetes and its many complications. A new review highlights how persistent changes in the body’s innate immune system may contribute to the development of diabetes, worsen disease progression, and create new opportunities for treatment.
A comprehensive new review examines the complex role of T cell exhaustion in organ transplantation, highlighting how this dysfunctional immune state can both promote graft tolerance and create vulnerabilities to infection and malignancy. The authors explore the molecular, epigenetic, transcriptional, and metabolic mechanisms underlying T cell exhaustion and discuss emerging strategies to intentionally induce or modulate exhaustion as a therapeutic tool in transplantation medicine.
A growing understanding of purinergic signaling is reshaping how scientists view osteoarthritis (OA), revealing an intricate communication network that influences joint inflammation, cartilage degeneration, bone remodeling, and chronic pain. A new review article highlights how disruptions in this signaling system may play a central role in disease progression while identifying promising opportunities for more targeted therapies that could slow or modify the course of OA rather than simply relieve symptoms.